相关实验视频

Updated: Jan 11, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

维林1预测了肝细胞癌中的存活率和辅助性TACE反应

Dongjun Luo¹, Chen Wang², Beicheng Sun¹

¹Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.

Cancer genetics

|November 14, 2025

概括

研究人员确定Villin1 (VIL1) 是一个关键基因,影响肝细胞癌 (HCC) 中透管动脉化学血栓化 (TACE) 的有效性. 高VIL1表达预测TACE反应不佳,这表明VIL1是HCC治疗结果的潜在生物标志物.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物标志物发现发现

背景情况:

过导管动脉化学栓塞 (TACE) 是肝细胞癌 (HCC) 的标准治疗方法.
识别TACE在HCC中有效性的预测生物标志物对于个性化治疗策略至关重要.
基因表达模式可能对HCC患者的TACE反应具有关键洞察力.

研究的目的:

确定与TACE在肝细胞癌 (HCC) 疗效相关的关键基因.
探索Villin1 (VIL1) 作为HCC中TACE反应的预测生物标志物的潜力.
分析VIL1表达与HCC患者预后以及TACE疗效之间的相关性.

主要方法:

权重基因共同表达网络分析 (WGCNA) 应用于基因表达综合 (GEO) 数据集 GSE104580.
鉴定了差异表达基因 (DEG),并分析了与TACE疗效相关的关键模块.
蛋白质与蛋白质相互作用 (PPI) 网络分析被用来选核心基因,在临床队列中进行验证.

主要成果:

确定Villin1 (VIL1) 是一个核心基因,与HCC的TACE反应有显著的关联.
与正常组织相比,VIL1在HCC组织中表达高.
在发现和验证队列中,高VIL1表达与HCC预后不佳以及TACE疗效降低相关.

结论:

该研究确定Villin1 (VIL1) 是TACE在肝细胞癌 (HCC) 疗效的潜在预测生物标志物.
高VIL1表达与TACE有效性降低和HCC患者的治疗结果较差有关.
对于VIL1在指导HCC的TACE治疗决策中的作用,需要进一步调查.

关键词:

在HCC中,HCC是HCC.这是TACE的税率.在WGCNA中,WGCNA是WGCNA.

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...